ECP 2023 Final Programme

Tuesday, 12 Sept 189 ECP 2023 Dublin LS-13 Industry Symposium 13:00–14:30 Liffey Hall 2 Opportunities to improve patient selection in lung cancer: evolving practice in the pathology lab (AstraZeneca) Chair: Alexander Yarunin, United Kingdom 001 13:00–13:10 Welcome and introduction Alexander Yarunin, United Kingdom 002 13:10–13:35 Early-stage lung cancer diagnostic testing including pathologic complete response M. Angeles Montero Fernandez, United Kingdom 003 13:35–13:55 Discussion and Q&A (All Faculty) Alexander Yarunin, United Kingdom 004 13:55–14:15 ctDNA: diagnostics applications across the lung cancer care continuum David Gonzalez de Castro, United Kingdom 005 14:15–14:30 Discussion and Q&A (All Faculty) Alexander Yarunin, United Kingdom LS-14 Industry Symposium 13:00–14:30 Liffey Hall 1 Pathology Implications for CEACAM5 As a Therapeutic Target in Advanced NSCLC (PER) Chair: Martin F. Dietrich, USA 001 13:00-13:10 Welcome, Introductions, Pre-Session Survey Martin F. Dietrich, USA 002 13:10-13:30 Targeting CEACAM5 in NSCLC: Clinical Rationale and Testing Strategies Speaker tbd 003 13:30-13:40 Clinical Validation of CEACAM5 as a Therapeutic Target Shirley M. Shiller, USA 004 13:40-13:55 Panel Discussion (All Faculty) Martin F. Dietrich, USA 005 13:55-14:00 Question and Answer Session (All Faculty) Martin F. Dietrich, USA LS-15 Industry Symposium 13:00–14:30 Wicklow Hall 1 How an Open, Scalable Digital Pathology Solution Can Improve Diagnostic Quality and Efficiency in Pathology Practice (Agilent) Chair: Alan Byrne, Ireland 001 13:00–13:10 Welcome & Agilent Digital Pathology Focus Alan Byrne, Ireland 002 13:10–13:25 How digital pathology has enabled the scale up of a novel capsule sponge test in the upper GI pathway Neil Ryan, United Kingdom 003 13:25–13:40 The need for an open digital pathology platform based on experiences at NHS GGC James Blackwood, United Kingdom 004 13:40–13:55 Implementation and validation of a digital pathology IMS and AI algorithm solution for PD-L1 in a reference lab environment Shawn Kinsey, USA 005 13:55–14:10 AI for accurate quantitation of therapeutic targets Paul Van Diest, The Netherlands 006 14:10–14:30 Panel Discussion (All Faculty) Alan Byrne, Ireland Industry Symposia